We are live on ! Find out more
LBPH

Longboard Pharmaceuticals, Inc. Common Stock
LBPH

Delisted

LBPH was delisted on the 29th of November, 2024.

Back to rankings

20 hedge funds and large institutions have $68.2M invested in Longboard Pharmaceuticals, Inc. Common Stock in 2021 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 3 increasing their positions, 7 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 3

18% more funds holding

Funds holding: 17 → 20 (+3)

5% less capital invested

Capital invested by funds: $71.7M → $68.2M (-$3.51M)

57% less repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 7

Holders
20
Holders Change
+3
Holders Change %
+17.65%
% of All Funds
0.35%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
3
Reduced
7
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
BCM
Bridgeway Capital Management
Texas
+$646K
2
TD Asset Management
TD Asset Management
Ontario, Canada
+$372K
3
V
Veritable
Delaware
+$189K
4
Bank of America
Bank of America
North Carolina
+$148K
5
Geode Capital Management
Geode Capital Management
Massachusetts
+$140K

Top Sellers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
-$3.22M
2
Millennium Management
Millennium Management
New York
-$497K
3
CAM
Cormorant Asset Management
Massachusetts
-$444K
4
Alyeska Investment Group
Alyeska Investment Group
Illinois
-$211K
5
Renaissance Technologies
Renaissance Technologies
New York
-$95K

LBPH Hedge Fund Activity: Q3 2021 in Review

20 of the 5,728 institutional investors tracked by Wall St. Rank reported a position in Longboard Pharmaceuticals, Inc. Common Stock (LBPH) for Q3 2021, worth a combined $68.2M — down 4.9% from $71.7M a quarter earlier.

Buyers outnumbered sellers: 6 funds opened new LBPH positions and 3 closed out — a net gain of 3 holders — while 3 added to existing stakes and 7 trimmed.

The largest buyer was Bridgeway Capital Management, opening a new position worth an estimated $646K. The largest seller was Fidelity Investments, cutting an estimated $3.22M.

  • 20 institutional investors held Longboard Pharmaceuticals, Inc. Common Stock (LBPH) as of Q3 2021, up from 17 in Q2 2021.
  • Funds reported $68.2M of Longboard Pharmaceuticals, Inc. Common Stock stock for Q3 2021, down 4.9% quarter-over-quarter.
  • 6 funds opened new Longboard Pharmaceuticals, Inc. Common Stock positions in Q3 2021 and 3 closed out, a net change of +3 holders.
  • The largest Longboard Pharmaceuticals, Inc. Common Stock buyer in Q3 2021 was Bridgeway Capital Management, an estimated $646K added.
  • The largest Longboard Pharmaceuticals, Inc. Common Stock seller in Q3 2021 was Fidelity Investments, an estimated $3.22M sold.

Based on aggregated 13F filings for Q3 2021.